Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
5.23
+0.12 (2.35%)
At close: Aug 3, 2026, 4:00 PM EDT
5.24
+0.01 (0.19%)
After-hours: Aug 3, 2026, 7:34 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $46.5 million as of August 3, 2026. Its market cap has increased by 209.13% in one year.
Market Cap
46.50M
Enterprise Value
36.50M
1-Year Change
209.13%
Ranking
Category
Stock Price
$5.23
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $46.50M, an increase of 25.29%. That is a compound annual growth rate of 3.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 46.50M | 292.98% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 48.64M |
| Immutep | 48.62M |
| RenovoRx | 48.26M |
| aTyr Pharma | 48.20M |
| BeyondSpring | 48.11M |
| INmune Bio | 47.72M |
| TScan Therapeutics | 47.71M |
| Impact BioMedical | 47.44M |